Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella, addressed a virtual conference amid doubts from some quarters regarding approval of the vaccine developed by the Indian company. On January 3, the Drugs Controller General of India (DCGI) had allowed emergency use of Bharat Biotech's Covaxin and the Oxford-AstraZeneca vaccine being manufactured in India by the Serum Institute of India as 'Covishield'. While listing his company's achievements and dismissing doubts regarding Covaxin's efficacy, Ella claimed that Indian companies and scientists are unjustly targeted. He added that Bharat Biotech is the only company in the world to have a BSL3 production facility. Watch the full video for more.
Connect with Hindustan Times
Press the bell icon on YouTube for all the latest updates from Hindustan Times
Like us on Facebook: [ Ссылка ]
Tweet us on Twitter: [ Ссылка ]
Follow us on Instagram: [ Ссылка ]
Find us on LinkedIn: [ Ссылка ]
Subscribe to Hindustan Times on Telegram: [ Ссылка ]
